First, we performed immunostaining for ASCL1 and NEUROD1 on SCLC tissue samples, collected from the primary tumour site, of 15 patients between 2019 and 2022 (Table S5), and observed that 14 samples were positive for ASCL1 (Fig. 1A, B). Here, ASCL1 is linked to small cell lung carcinoma.